The present work reports the effect of conjugation of the anticarcinogenic and antitumor soybean Bowman-Birk protease inhibitor (BBI) with amphiphilic block copolymer of ethylene oxide and propylene oxide (PEO-PPO) as well as with monoclonal antibody via clinical dextran (D) on tumor-targeted delivery of BBI.
- Ethylene oxide and propylene oxide block copolymer
- Soybean Bowman-Birk protease inhibitor (BBI)
ASJC Scopus subject areas
- Pharmaceutical Science